Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

BACKGROUND: Adjuvant therapy for T3N0 rectal cancer was controversial with respect to both radiation and the use of a combined regimen of chemotherapy. We evaluated both clinical features and biomarkers and sought to determine risk factors for those patients retrospectively. METHODS: A total of 122...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ji, Xu, Ye, Gu, Weilie, Peng, Junjie, Cai, Gang, Cai, Guoxiang, Sun, Wenjie, Shen, Weiqi, Cai, Sanjun, Zhang, Zhen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009675/
https://www.ncbi.nlm.nih.gov/pubmed/21156077
http://dx.doi.org/10.1186/1748-717X-5-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009675/
https://www.ncbi.nlm.nih.gov/pubmed/21156077
http://dx.doi.org/10.1186/1748-717X-5-118

Ejemplares similares